Cargando…

Hemoadsorption Treatment of Patients with Acute Infective Endocarditis during Surgery with Cardiopulmonary Bypass - A Case Series

INTRODUCTION: Infective endocarditis is a serious disease condition. Depending on the causative microorganism and clinical symptoms, cardiac surgery and valve replacement may be needed, posing additional risks to patients who may simultaneously suffer from septic shock. The combination of surgery ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Träger, Karl, Skrabal, Christian, Fischer, Guenther, Datzmann, Thomas, Schroeder, Janpeter, Fritzler, Daniel, Hartmann, Jan, Liebold, Andreas, Reinelt, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159853/
https://www.ncbi.nlm.nih.gov/pubmed/28525670
http://dx.doi.org/10.5301/ijao.5000583
_version_ 1783358668884934656
author Träger, Karl
Skrabal, Christian
Fischer, Guenther
Datzmann, Thomas
Schroeder, Janpeter
Fritzler, Daniel
Hartmann, Jan
Liebold, Andreas
Reinelt, Helmut
author_facet Träger, Karl
Skrabal, Christian
Fischer, Guenther
Datzmann, Thomas
Schroeder, Janpeter
Fritzler, Daniel
Hartmann, Jan
Liebold, Andreas
Reinelt, Helmut
author_sort Träger, Karl
collection PubMed
description INTRODUCTION: Infective endocarditis is a serious disease condition. Depending on the causative microorganism and clinical symptoms, cardiac surgery and valve replacement may be needed, posing additional risks to patients who may simultaneously suffer from septic shock. The combination of surgery bacterial spreadout and artificial cardiopulmonary bypass (CPB) surfaces results in a release of key inflammatory mediators leading to an overshooting systemic hyperinflammatory state frequently associated with compromised hemodynamic and organ function. Hemoadsorption might represent a potential approach to control the hyperinflammatory systemic reaction associated with the procedure itself and subsequent clinical conditions by reducing a broad range of immuno-regulatory mediators. METHODS: We describe 39 cardiac surgery patients with proven acute infective endocarditis obtaining valve replacement during CPB surgery in combination with intraoperative CytoSorb hemoadsorption. In comparison, we evaluated a historical group of 28 patients with infective endocarditis undergoing CPB surgery without intraoperative hemoadsorption. RESULTS: CytoSorb treatment was associated with a mitigated postoperative response of key cytokines and clinical metabolic parameters. Moreover, patients showed hemodynamic stability during and after the operation while the need for vasopressors was less pronounced within hours after completion of the procedure, which possibly could be attributed to the additional CytoSorb treatment. Intraoperative hemoperfusion treatment was well tolerated and safe without the occurrence of any CytoSorb device-related adverse event. CONCLUSIONS: Thus, this interventional approach may open up potentially promising therapeutic options for critically-ill patients with acute infective endocarditis during and after cardiac surgery, with cytokine reduction, improved hemodynamic stability and organ function as seen in our patients.
format Online
Article
Text
id pubmed-6159853
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-61598532018-10-11 Hemoadsorption Treatment of Patients with Acute Infective Endocarditis during Surgery with Cardiopulmonary Bypass - A Case Series Träger, Karl Skrabal, Christian Fischer, Guenther Datzmann, Thomas Schroeder, Janpeter Fritzler, Daniel Hartmann, Jan Liebold, Andreas Reinelt, Helmut Int J Artif Organs Short Communication INTRODUCTION: Infective endocarditis is a serious disease condition. Depending on the causative microorganism and clinical symptoms, cardiac surgery and valve replacement may be needed, posing additional risks to patients who may simultaneously suffer from septic shock. The combination of surgery bacterial spreadout and artificial cardiopulmonary bypass (CPB) surfaces results in a release of key inflammatory mediators leading to an overshooting systemic hyperinflammatory state frequently associated with compromised hemodynamic and organ function. Hemoadsorption might represent a potential approach to control the hyperinflammatory systemic reaction associated with the procedure itself and subsequent clinical conditions by reducing a broad range of immuno-regulatory mediators. METHODS: We describe 39 cardiac surgery patients with proven acute infective endocarditis obtaining valve replacement during CPB surgery in combination with intraoperative CytoSorb hemoadsorption. In comparison, we evaluated a historical group of 28 patients with infective endocarditis undergoing CPB surgery without intraoperative hemoadsorption. RESULTS: CytoSorb treatment was associated with a mitigated postoperative response of key cytokines and clinical metabolic parameters. Moreover, patients showed hemodynamic stability during and after the operation while the need for vasopressors was less pronounced within hours after completion of the procedure, which possibly could be attributed to the additional CytoSorb treatment. Intraoperative hemoperfusion treatment was well tolerated and safe without the occurrence of any CytoSorb device-related adverse event. CONCLUSIONS: Thus, this interventional approach may open up potentially promising therapeutic options for critically-ill patients with acute infective endocarditis during and after cardiac surgery, with cytokine reduction, improved hemodynamic stability and organ function as seen in our patients. SAGE Publications 2018-01-26 2017-05 /pmc/articles/PMC6159853/ /pubmed/28525670 http://dx.doi.org/10.5301/ijao.5000583 Text en © 2017 SAGE Publications. http://www.creativecommons.org/licenses/by-nc-nd/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (http://www.creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Short Communication
Träger, Karl
Skrabal, Christian
Fischer, Guenther
Datzmann, Thomas
Schroeder, Janpeter
Fritzler, Daniel
Hartmann, Jan
Liebold, Andreas
Reinelt, Helmut
Hemoadsorption Treatment of Patients with Acute Infective Endocarditis during Surgery with Cardiopulmonary Bypass - A Case Series
title Hemoadsorption Treatment of Patients with Acute Infective Endocarditis during Surgery with Cardiopulmonary Bypass - A Case Series
title_full Hemoadsorption Treatment of Patients with Acute Infective Endocarditis during Surgery with Cardiopulmonary Bypass - A Case Series
title_fullStr Hemoadsorption Treatment of Patients with Acute Infective Endocarditis during Surgery with Cardiopulmonary Bypass - A Case Series
title_full_unstemmed Hemoadsorption Treatment of Patients with Acute Infective Endocarditis during Surgery with Cardiopulmonary Bypass - A Case Series
title_short Hemoadsorption Treatment of Patients with Acute Infective Endocarditis during Surgery with Cardiopulmonary Bypass - A Case Series
title_sort hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass - a case series
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159853/
https://www.ncbi.nlm.nih.gov/pubmed/28525670
http://dx.doi.org/10.5301/ijao.5000583
work_keys_str_mv AT tragerkarl hemoadsorptiontreatmentofpatientswithacuteinfectiveendocarditisduringsurgerywithcardiopulmonarybypassacaseseries
AT skrabalchristian hemoadsorptiontreatmentofpatientswithacuteinfectiveendocarditisduringsurgerywithcardiopulmonarybypassacaseseries
AT fischerguenther hemoadsorptiontreatmentofpatientswithacuteinfectiveendocarditisduringsurgerywithcardiopulmonarybypassacaseseries
AT datzmannthomas hemoadsorptiontreatmentofpatientswithacuteinfectiveendocarditisduringsurgerywithcardiopulmonarybypassacaseseries
AT schroederjanpeter hemoadsorptiontreatmentofpatientswithacuteinfectiveendocarditisduringsurgerywithcardiopulmonarybypassacaseseries
AT fritzlerdaniel hemoadsorptiontreatmentofpatientswithacuteinfectiveendocarditisduringsurgerywithcardiopulmonarybypassacaseseries
AT hartmannjan hemoadsorptiontreatmentofpatientswithacuteinfectiveendocarditisduringsurgerywithcardiopulmonarybypassacaseseries
AT lieboldandreas hemoadsorptiontreatmentofpatientswithacuteinfectiveendocarditisduringsurgerywithcardiopulmonarybypassacaseseries
AT reinelthelmut hemoadsorptiontreatmentofpatientswithacuteinfectiveendocarditisduringsurgerywithcardiopulmonarybypassacaseseries